Back to Journals » Drug Design, Development and Therapy » Volume 11

Clinical potential of SLAMF7 antibodies – focus on elotuzumab in multiple myeloma

Total article views   HTML views PDF downloads Totals
14,584 Dovepress* 13,017+ 1,777 14,794
PubMed Central* 1,567 858 2,425
Totals 14,584 2,635 17,219
*Since 20 March 2017
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 1 2

View citations on PubMed Central and Google Scholar